Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation

Abstract

It is widely postulated that systemic inflammation related to lung infections is largely caused by cytokine translocation from the lungs into the systemic circulation but there is a paucity of animal models to evaluate this hypothesis. In this proof-of-concept study, we developed a murine model to determine whether interleukin (IL)-6, a primary inflammatory cytokine, translocates following airway exposure to endotoxin. We collected central venous blood from the right atrium and arterial blood from the aorta simultaneously at 4 h and 24 h following intratracheal exposure to endotoxin (25 mg) and measured IL-6 in the serum and broncho-alveolar lavage (BAL) fluid (n = 33 mice). We repeated the experiment following 3 d of treatment with dexamethasone (n = 31 mice). Without stimulation, there was no significant arteriovenous gradient (3 pg/ml with interquartile range [IQR] of 3—5 pg/ml in arterial versus 18 pg/ml with IQR of 8—24 pg/ml in venous serum; P = 0.86). A significant arteriovenous difference was observed by 4 h post-exposure to endotoxin (2813 pg/ml with IQR of 1578—4316 pg/ml in arterial versus 1282 pg/ml with IQR of 778—2699 pg/ml in venous serum; P50.0001). The rise in the BAL IL-6 levels correlated with the increases in the arterial serum levels (P50.0001). Administration of intraperitoneal dexamethasone for 3 d attenuated the increased arteriovenous gradient. This murine model facilitates the estimation of cytokine translocation across the lungs and evaluation of compounds to modulate this gradient.

Keywords

Endotoxin interleukin-6 translocation systemic inflammation

References

Chalmers JD , Singanayagam A. , Hill AT C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219-225.

Gompertz S. , Bayley DL , Hill SL , Stockley RA Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 2001; 56: 36-41.

Nel AE , Strachan AF , Welke HE , de Beer FC Acute phase response in bronchiectasis and bronchus carcinoma. Respiration 1985; 47: 196-200.

Russell JA Management of sepsis. N Engl J Med 2006; 355: 1699-1713.

Tyburski JG , Dente C. , Wilson RF et al. Differences in arterial and mixed venous IL-6 levels: the lungs as a source of cytokine storm in sepsis. Surgery 2001; 130: 748-751.

Oberholzer A. , Souza SM , Tschoeke SK et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis . Shock 2005; 23: 488-493.

Pathan N. , Hemingway CA , Alizadeh AA et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363: 203-209.

Pettila V. , Hynninen M. , Takkunen O. , Kuusela P. , Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-1225.

Wakefield CH , Barclay GR , Fearon KC et al. Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish Sepsis Intervention Group. Br J Surg 1998; 85: 818-825.

10.

Kellum JA , Kong L. , Fink MP et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med 2007; 167: 1655-1663.

11.

Schefold JC , von Haehling S. , Corsepius M. et al. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock 2007; 28: 418-425.

12.

Hasday JD , Bascom R. , Costa JJ , Fitzgerald T. , Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829-835.

13.

Hollingsworth JW , Chen BJ , Brass DM et al. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 2005; 171: 806-813.

14.

Giebelen IA , van Westerloo DJ , LaRosa GJ , de Vos AF , van der Poll T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 2007; 28: 700-703.

15.

Cheng C. , Pounds S. False discovery rate paradigms for statistical analyses of microarray gene expression data. Bioinformation 2007; 1: 436-446.

16.

Terashima T. , Wiggs B. , English D. , Hogg JC , van Eeden SF The effect of cigarette smoking on the bone marrow. Am J Respir Crit Care Med 1997; 155: 1021-1026.

17.

van Eeden SF , Sin DD Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224-238.

18.

Rull M. , Clayburne G. , Sieck M. , Schumacher HR Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch. Rheumatology ( Oxford) 2003; 42: 1093-1100.

19.

Umeno E. , McDonald DM , Nadel JA Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation. J Clin Invest 1990 ; 85: 1905-1908.

20.

Muhlfeld C. , Gehr P. , Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 2008; 138: 387-391.

21.

Moller W. , Felten K. , Sommerer K. et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 2008; 177: 426-432.

22.

Nemmar A. , Hamoir J. , Nemery B. , Gustin P. Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model. Toxicology 2005; 208: 105-113.

23.

Levine MM , Kaper JB , Black RE , Clements ML New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev 1983; 47: 510-550.

24.

Martin TR Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000; 23: 128-132.

25.

Gamble L. , Bagby GJ , Quinton LJ et al. The systemic and pulmonary lipopolysaccharide binding protein response to intratracheal lipopolysaccharide. Shock 2009; 31: 212-217.

26.

Ek A. , Palmberg L. , Larsson K. The effect of fluticasone on the airway inflammatory response to organic dust . Eur Respir J 2004; 24: 587-593.

27.

Khair OA , Davies RJ , Devalia JL Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996; 9: 1913-1922.

28.

Danesh J. , Kaptoge S. , Mann AG et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5: e78.

29.

Hong DS , Angelo LS , Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapeutics . Cancer 2007; 110: 1911-1928.

30.

Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine . Arthritis Res Ther 2006; 8: S2.

31.

Mudter J. , Neurath MF IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007 ; 13: 1016-1023.

32.

Rose-John S. , Waetzig GH , Scheller J. , Grotzinger J. , Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007; 11: 613-624.

33.

Tamagawa E. , Bai N. , Morimoto K. et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol 2008; 295: L79-L85.

34.

Ishii H. , Hayashi S. , Hogg JC et al. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir Res 2005 ; 6: 87.